Home

CollPlant Biotechnologies Ltd. (CLGN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about CollPlant Biotechnologies Ltd. (CLGN)

Go deeper and ask any question about CLGN

Company Performance

Current Price

as of Sep 13, 2024

$5.01

P/E Ratio

N/A

Market Cap

$57.39M

Description

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Metrics

Overview

  • HQRehovot, TA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerCLGN
  • Price$5.0099+3.72%

Trading Information

  • Market Cap$57.39M
  • Float68.76%
  • Average Daily Volume (1m)8,789
  • Average Daily Volume (3m)12,971
  • EPS-$1.53

Company

  • Revenue$0.69M
  • Rev Growth (1yr)-97.55%
  • Net Income-$4.21M
  • Gross Margin-220.08%
  • EBITDA Margin-1,664.66%
  • EBITDA-$4.15M
  • EV$41.16M
  • EV/Revenue59.74
  • P/EN/A
  • P/S83.29
Documents